Quinoa VS Reliv

Dr. Alfredo Galvez

Renowned research scientist at the Center of Excellence in Nutritional Genomics at UC Davis and lead scientific advisor at SL Technologies, a Reliv subsidiary. Dr. Galvez first discovered lunasin in 1996 during research at UC Berkley to improve the nutritional profile of soy protein. Dr. Galvez serendipitously discovered the anti-cancer properties of the lunasin peptide, while working as a postdoctoral researcher on a project to increase the methionine content of soy protein at UC Berkeley in the late 1990's.

Lunasin was first investigated as a factor that might prevent cancer cells from dividing and multiplying. Dr. Galvez made his initial discoveries as part of Professor De Lumen's team at UC Berkeley. He discovered that the soy protein "lunacin" could prevent normal cells from becoming cancerous. He says "I immediately knew it would have some practical effect for the health benefit of man-kind." In addition, unlike other cancer preventive agents, while killing off potentially cancerous cells, the peptide poses no detriment to neighboring healthy cells. It even significantly reduces the risk of those cells becoming cancerous as well. Their team called it Lunasin, after the Filipino word “lunas” which means “cure.” 

More than 40 peer-reviewed and published studies have affirmed the health benefits of Lunasin ever since its discovery (“Lunasin Research,” 2011). This discovery has contributed greatly in the search for more natural and accessible cancer prevention methods and has definitely brought pride to the Filipino people. The mechanism of action for Lunasin and cancer prevention was included in prestigious journals, such as Nature Biotechnology and the Journal of Cancer Research. As Dr. Galvez continued to study Lunasin, it became evident that the soy peptide had another powerful mechanism of action– lowering cholesterol. 

While soy has long been linked to heart health, recent studies indicate that protection of the lunasin peptide component so that sufficient amounts are bioavailable once inside the body is the key to its ability to lower LDL (bad) cholesterol.

Dr Galvez says "since it comes form a natural source, it's already considered safe by the FDA. Although Lunasin was first recognized as a key factor for stopping cancer cells from replicating, further studies showed that the soy peptide also had another powerful property—sufficient amounts of lunasin peptide in one’s system can effectively lower LDL (bad) cholesterol.

The FDA had previously approved soy for the prevention of cardiovascular disease.  In 2012 lunasin researcher Alfredo Galvez identified that lunasin was the aspect of soy protein responsible for this medical application. The American Heart Association has endorsed the benefits of lunasin and published Dr Galvez’s research. (sourced from Lunasin.com and Wikipedia.org)

Studies have shown evidence that lunasin has cholesterol-lowering properties. Longer term associations between the eating of soy beans and soy products, and the lowering of cholesterol, have been attributed to lunasin. The process by which lunasin lowers cholesterol, is the inhibition of enzymes present in the liver, by reducing the gene expression for HMG-CoA reductase. Lunasin also has been shown to increase the transcription of LDL receptor mRNA, which allows better passage of plasma LDL cholesterol.

The lower incidence of breast cancer among Asian women compared with Western countries has been partly attributed to soy in the Asian diet, leading to efforts to identify the bioactive components that are responsible. Soy Bowman Birk Inhibitor Concentrate (BBIC) is a known cancer preventive agent now in human clinical trials. Methodology/Principal Findings: The objectives of this work are to establish the presence and delineate the in vitro activity of lunasin.

Dr Carl Hastings

Dr. Carl Hastings joined Reliv in 1988 Dr. Hastings obtained a Ph.D. in food science from the University of Illinois and has spent nearly 40 years in food product research and development. In 2009 Dr. Hastings was elected to the board of directors of the Council for Responsible Nutrition, the leading trade organization for the nutritional supplements industry. In 2013, Reliv's LunaRichX was awarded a People's Choice Stevie Award for Favorite New Products. The Stevies recognize outstanding performances in the workplace worldwide. LunaRichX is concentrated lunasin, and is a factor in epigenetics cell health. Lunasin is a peptide found naturally in soy that is responsible for many of soy’s documented health benefits, including heart health, cholesterol management, inflammation reduction, improved immunity and overall cellular health. The launch of LunaRich™ and Reliv’s recent Communitas and marketing awards have generated lots of buzz around Reliv HQ recently. And the excitement continues with the announcement that Vice Chairman and Chief Scientific Officer Dr. Carl Hastings has been elected to the Council for Responsible Nutrition – International board. CRN-I provides science-based information to regulators, healthcare professionals and the media – particularly those outside the United States. The organization works for the safety and benefit of dietary ingredients and dietary supplements, and promotes sound nutrition and food safety policies rooted in science. The organization has held two scientific symposiums that have brought together international regulators with the scientific community to address issues relevant to international policy. Dr. Carl’s election to this board is a great honor, and brings even more global recognition to the Reliv brand. reliv.com

Reliv's Humble beginings.

What is Reliv? Dr. Ted Kalogris worked with the World Health Organization in the 50's warning about the declining nutrients in our food system.

Dr. Ted was adamant that if you provide the body with the right fuel/nutrition then the body will carry out a process of repairing itself. He added "For an individual to be healthy, chemicals, minerals and vitamins must be balanced through proper nutrition." Dr. Ted achieved this mindset with a vigorous pursue of his project, giving over 10yrs of research development and over 850 separate trials of dedication, he consumed the end results now know as Classic today. This led to him eventually being able to leave his wheel chair when all available medical experts concluded he never would. In his own struggle for a better quality of life, Dr. Ted created the first patented nutritional product that has left a legacy of change in peoples lives all over the world. RCN# 173198904 http://bit.ly/1nOkf2B